Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Mindfulness-based psychoeducation for schizophrenia patients

Official title: The Effect of Mindfulness-Based Psychoeducation Programme Given Individually to Schizophrenia Patients on Internalised Stigma and Healthy Lifestyle Behaviours

Run by Kastamonu University · NCT06882538 · Data updated 2026-11-12

This study is testing a mindfulness program to see if it can help people with schizophrenia feel better about themselves and adopt healthier habits.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorKastamonu University
Academic / other
Locations1 site (Kastamonu, Central)
StatusRecruiting
StartedFebruary 14, 2025
Main results expectedFebruary 20, 2025
Study endsMarch 15, 2025
Registry record updatedMarch 18, 2025
Trial IDNCT06882538 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals diagnosed with schizophrenia who are registered and actively participating in treatment at the Community Mental Health Centre.

Probably not a fit

Patients who have not been diagnosed with schizophrenia or those unwilling to participate in the study will not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the impact of a mindfulness-based psychoeducation program on individuals diagnosed with schizophrenia, focusing on reducing internalized stigma and promoting healthy lifestyle behaviors. The program will be administered individually to patients registered at the Kastamonu Community Mental Health Centre over a six-week period. Participants will be assessed before and after the intervention using various scales to measure stigma and lifestyle changes. The study employs a pre-test-post-test design with control and experimental groups to evaluate the effectiveness of the intervention.

Why it matters

Potential benefit: If successful, this program could significantly improve the quality of life and self-perception of patients with schizophrenia.

How similar studies have gone: While there have been interventional studies on stigma in schizophrenia, this specific approach combining mindfulness and psychoeducation is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Having been diagnosed with schizophrenia
2. TRSM registered and continuing
3. Acceptance to work and training

Exclusion Criteria:

1. Have not been diagnosed with schizophrenia
2. If he/she does not agree to participate in the study
3. If not registered with TRSM

Where it's running

  • Kastamonu Community Mental Health Centre
    Kastamonu, Central, Turkey (Türkiye)
    Recruiting

Study contacts

  • Principal investigator: Havva K KAÇAN, ASSOCIATE PROFESSOR DOCTOR — Kastamonu University
  • Study coordinator: Havva K KAÇAN, ASSOCIATE PROFESSOR DOCTOR
  • Email: hkacan@kastamonu.edu.tr
  • Phone: 05057753893

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.